Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz

Patent Law

: IPBiz

StemCells still going after Neuralstem

By Lawrence B. Ebert, Esq.

Forbes (AP) reports on May 12: Clinical-stage biotechnology company StemCells Inc. said Monday [May 12] it filed a second patent lawsuit against Neuralstem in a California federal court, alleging infringement of two patents related to human neural stem cells.

There was the discussion of litigate vs. license:

"While we are disappointed that Neuralstem chose to escalate matters, we have a duty to our shareholders to protect our good name and the significant value of our intellectual property portfolio built over the years," StemCells Chief Executive Officer Martin McGlynn said in a statement. "Litigation of this type can be very time consuming and expensive and might have been avoided had Neuralstem chosen to negotiate a license as others have."

See also

http://ipbiz.blogspot.com/2008/04/battling-press-releases-on-meaning-of.html

Full post as published by IPBiz on May 12, 2008 (boomark / email).